Ignite Creation Date:
2025-12-24 @ 11:17 PM
Ignite Modification Date:
2026-02-21 @ 1:51 AM
Study NCT ID:
NCT06848556
Status:
TERMINATED
Last Update Posted:
2025-02-27
First Post:
2025-02-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluate the Effect of Tirazamine on Primary Liver Cancer.
Sponsor:
Zhejiang Raygene Pharmaceuticals Co., Ltd
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
LT005
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None